Status:
RECRUITING
Artificial Intelligence (AI) Analysis of Synchronized Phonocardiography (PCG) and Electrocardiogram(ECG)
Lead Sponsor:
Ruijin Hospital
Conditions:
Heart Failure
Eligibility:
All Genders
18-100 years
Brief Summary
The diagnosis of depressed left ventricular ejection fraction (dLVEF) (EF\<50%) depends on golden standard ultrasound cardiography (UCG). A wearable synchronized phonocardiography (PCG) and electrocar...
Detailed Description
The synchronized PCG and ECG is wirelessly paired with the WenXin Mobile application, allowing for simultaneous recording and visualization of PCG and ECG. These features uniquely enable this device t...
Eligibility Criteria
Inclusion
- Attendance at RuiJin hospital for UCG
- Signed dated informed consent
- Commit to follow the research procedures and cooperate in the implementation of the whole process research
- UCG has been completed
- Age ≥ 18
- At least 8 consecutive cycles of sinus rhythm can be recorded
Exclusion
- Patients with pacemakers
- Complete left bundle branch block or block or QRS wave widening\>120ms
- Left chest skin damaged or allergic to patch
- Refusal to participate
Key Trial Info
Start Date :
August 25 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2028
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06009718
Start Date
August 25 2023
End Date
June 1 2028
Last Update
January 16 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital, Shanghai Jiaotong School of Medicine
Shanghai, China, 200025
2
Shanghai Chest Hospital, Shanghai Jiao Tong University School Of Medicine
Shanghai, China, 200030
3
Shanghai East Hospital
Shanghai, China, 200123